www.sec.gov/Archives/edgar/data/1307752/0001144204-09-0 -
[Cached Version]
Published on: 4/10/2009
Last Visited: 4/13/2009
Analoui, Kerpelman, Knafel, Mintz, Phelps and Walts are "independent" as defined by Nasdaq and under Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as that term relates to membership on the Board of Directors.
...
Dan I. Kerpelman, age 50, has served on the Company's Board of Directors since May 2008.
He is the President and Chief Executive Officer of Bio-Optronics, Inc., a healthcare workflow software company based in Rochester, New York and Commugny, Switzerland. He also acts as a consultant to industry, private equity and companies relating to health care and medical technology matters.
Previously, he was Chief Executive Officer of Société Generale de Surveillance, SA in Geneva, Switzerland, a company involved in testing, inspection and corporate certifications.
From June 2002 through March 2005, Mr. Kerpelman was Senior Vice President of Eastman Kodak and President of its Health Imaging Group, which focused on medical and dental imaging equipment, consumables and information technology.
He spent most of his earlier career with GE Healthcare.
Mr. Kerpelman is an engineer and holds a MBA from Northwestern University.
He serves on the Board of Directors of XCounter, AB, Cotecna SA and the University of Rochester Medical Center.
...
The Compensation Committee is currently composed of Terence A. Walts (Chairman), Daniel I. Kerpelman, and Colby Chandler.
...
Dan Kerpelman
...
Klimasewski, Knafel, Markin, Kerpelman, Walts, Chandler, Analoui, Mintz and Phelps, respectively.